Abstract
This study investigated the acute effects of Δ9-tetrahydrocannabinol (THC) on four behavioral measures of impulsivity in recreational marijuana users. Although impulsive behavior has been studied using several different measures of impulsivity, few studies have utilized more than one of these measures on a single cohort. In this study, 37 healthy men and women participated in three sessions, in which they received capsules containing placebo, 7.5, or 15 mg THC in randomized order under double-blind conditions. Subjects were tested on the following four tasks: the Stop task, which measures the ability to inhibit a prepotent motor response; a Go/no-go task; a Delay discounting task, which measures the value of delayed or uncertain reinforcers; and a time estimation task, which measures alterations in time perception through a time reproduction procedure. Subjects also completed mood questionnaires and general measures of performance. THC produced its expected effects on subjective measures including increases in ARCI euphoria and marijuana scales. THC increased impulsive responding on the Stop task but did not affect performance on either the Go/no-go or Delay or Probability discounting tasks. On the time reproduction task, THC increased estimates of the duration of short intervals while not affecting estimates of longer intervals. There were no significant correlations between the four tasks either before or after drug administration. These results suggest that THC may increase certain forms of impulsive behavior while not affecting other impulsive behaviors. The dissociations between the four measures of impulsivity suggest that impulsivity is an assemblage of distinct components rather than a unitary process.
Similar content being viewed by others
Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
References
Ainslie G (1975). Specious reward: a behavioral theory of impulsiveness and impulse control. Psychol Bull 82: 463–496.
Ameri A (1999). The effects of cannabinoids on the brain. Prog Neurobiol 58: 315–348.
American Psychiatric Association (1994). Diagnostic and Statistical Manual of Mental DISORDERS, DSM-IV, 4th edn. American Psychiatric Association: Washington, DC.
Ashton CH (2001). Pharmacology and effects of cannabis: a brief review. Br J Psychiatry 178: 101–106.
Barkley RA (1997). ADHD and the Nature of Self-control. The Guileford Press: New York.
Barkley RA (2002). TimeTest application. University of Massachussets Medical Center, Massachussets.
Barkley RA, Murphy KR, Bush T (2001). Time perception and reproduction in young adults with attention deficit hyperactivity disorder. Neuropsychology 15: 351–360.
Brandt J, Corwin J, Krafft L (1992). Is verbal recognition memory really different in Huntington's and Alzheimer's disease. J Clin Exp Neuropsychol 14: 73–84.
Chait LD, Fischman MW, Schuster CR (1985). ‘Hangover’ effects the morning after marijuana smoking. Drug Alcohol Depend 15: 229–238.
Chait LD, Pierri J (1992). Effects of smoked marijuana on human performance: a critical review. In: Murphy L, Barke A (eds). Marijuana/Cannabinoids: Neurobiology and Neurophysiology. CRC Press: Ann Arbor.
Crean JP, de Wit H, Richards JB (2000). Reward discounting as a measure of impulsive behavior in a psychiatric outpatient population. Exp Clin Psychopharmacol 2: 155–162.
Crean J, Richards JB, de Wit H (2002). Impulsive behavior in men with and without a family history of alcoholism: effects of tryptophan depletion. Behav Brain Res 136: 349–357.
de Wit H, Crean J, Richards JB (2000). Effects of D-amphetamine and ethanol on a measure of behavioral inhibition in humans. Behav Neurosci 114: 830–837.
de Wit H, Enggasser J, Richards JB (2002). Effects of D-amphetamine on behavioral measures of impulsivity in humans. Neuropsychopharmacology 27: 813–825.
de Wit H, Kirk J, Justice A (1998). Behavioral pharmacology of cannabinoids. In: Tarter et al (eds). Handbook of Substance Abuse: Neurobehavioral Pharmacology. Plenum Press: New York.
Derogatis L (1983). SCL-90-R Manual-II. Clinical Psychometric Research: Towson.
Diana M, Melis M, Gessa GL (1998). Increase in meso-prefrontal dopaminergic activity after stimulation of CB1 receptors by cannabinoids. Eur J Neurosci 10: 2825–2832.
Evenden JL, Ryan CN (1999). The pharmacology of impulsive behaviour in rats VI: the effects of ethanol and selective serotonergic drugs on response choice with varying delays of reinforcement. Psychopharmacology (Berl) 146: 413–421.
Evenden JL (1999). Varieties of impulsivity. Psychopharmacology 146: 348–361.
Green L, Fry AF, Myerson J (1994). Discounting of delayed rewards: a life-span comparison. Psychol Sci 5: 33–36.
Haertzen CH, Hickey JE (1987). Addiction research center inventory (ARCI): measurement of euphoria and other drug effects. In: Bozarth MA (ed). Methods of Assessing the Reinforcing Properties of Abused Drugs. Springer-Verlag: New York.
Hart CL, van Gorp W, Haney M, Foltin RW, Fischman MW (2001). Effects of acute smoked marijuana on complex cognitive performance. Neuropsychopharmacology 25: 757–765.
Johnson MW, Bickel WK (2002). Within-subject comparison of real and hypothetical money rewards in delay discounting. J Exp Anal Behav 77: 129–146.
Johanson CE, Uhlenhuth EH (1980). Drug preference and mood in humans: diazepam. Psychopharmacology (Berl) 71: 269–273.
Kirk JM, de Wit H (1999). Responses to oral delta-9-tetrahydrocannabinol in frequent and infrequent marijuana users. Pharmacol, Biochem Behav 63: 137–142.
Logan GD, Sachar RJ, Tannock R (1997). Impulsivity and inhibitory control. Psychol Sci 8: 60–64.
Madden GJ, Petry NM, Badger GJ, Bickel W (1997). Impulsive and self-control choices in opioid-dependent patients and non-drug-using control participants: drug and monetary rewards. Exp Clin Psychopharmacol 5: 256–262.
Martin W, Sloan J, Sapira J, Jasinski D (1971). Physiologic, subjective, and behavioral effects of amphetamine, methamphetamine, ephedrine, phenmetrazine, and methylphenindate in man. Clin Pharmacol Ther 12: 245–258.
McNair D, Lorr M, Droppleman L (1971). Profile of Mood States. Educational and Industrial Testing Service: San Diego.
Meck WH (1996). Neuropharmacology of timing and time perception. Brain Res Cogn Brain Res 3: 227–242.
Mischel W, Shoda Y, Rodriguez ML (1989). Delay of gratification in children. Science 244: 933–938.
Mitchell S (1999). Measures of impulsivity in cigarette smokers and non-smokers. Psychopharmacology 146: 455–464.
Newman JP, Widom CS, Nathan S (1985). Passive avoidance in syndromes of disinhibition: Psychopathology and extraversion. J Personality Soc Psychol 48: 1316–1327.
Patton JH, Stanford MS, Barratt ES (1995). Factor structure of the Barratt Impulsiveness Scale. J Clin Psychol 51: 768–774.
Richards JB, Sabol KE, de Wit H (1999a). Effects of methamphetamine on the adjusting amount procedure, a model of impulsive behavior in rats. Psychopharmacology (Berl) 146: 432–439.
Richards JB, Zhuang L, Mitchell SH, de Wit H (1999b). Delay or probability discounting in a model of impulsive behavior: effect of alcohol. J Exp Anal Behav 71: 121–143.
Roger RD, Owen AM, Middleton HC, Williams EJ, Pickard JD, Sahakian BJ et al (1999). Choosing between small, likely rewards and large, unlikely rewards activates inferior and orbital prefrontal cortex. J Neurosci 20: 9029–9038.
Rubia K, Russell T, Overmeyer S, Brammer MJ, Bullmore ET, Sharma T et al (2001). Mapping motor inhibition: conjunctive brain activations across different versions of go/no-go and stop tasks. Neuroimage 13: 250–261.
Schulze GE, McMillan DE, Bailey JR, Scallet A, Ali SF, Slikker W (1988). Acute effects of delta-9-tetrahydrocannabinol in rhesus monkeys measured by performance in a battery of complex operant tests. J Pharmacol Exp Ther 14: 178–186.
Selzer ML (1971). The Michigan Alcoholism Screening Test: the quest for a new diagnostic instrument. Am J Psychiatry 127: 1653–1658.
Solanto MV (1998). Neuropsychopharmacological mechanisms of stimulant drug action in attention-deficit hyperactivity disorder: a review and integration. Behav Brain Res 94: 127–152.
Sonuga-Barke EJ (2002). Psychological heterogeneity in AD/HD—a dual pathway model of behavior and cognition. Behav Brain Res 130: 26–29.
Wade TR, de Wit H, Richards JB (2000). Effects of dopaminergic drugs on delayed reward as a measure of impulsive behavior in rats. Psychopharmacology 150: 90–101.
Wechsler D (1958). The Measure and Appraisal of Adult Intelligence. Williams & Wilkins: Baltimore, MD.
United States Department of Health and Human Services National Household Survey on Drug Abuse (2000). Substance abuse and mental health administration. Washington, DC.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
McDonald, J., Schleifer, L., Richards, J. et al. Effects of THC on Behavioral Measures of Impulsivity in Humans. Neuropsychopharmacol 28, 1356–1365 (2003). https://doi.org/10.1038/sj.npp.1300176
Received:
Revised:
Accepted:
Published:
Issue date:
DOI: https://doi.org/10.1038/sj.npp.1300176
Keywords
This article is cited by
-
Repeated Δ-9-Tetrahydrocannabinol administration dose dependently increases stablished schedule-induced drinking
Psychopharmacology (2024)
-
Substance Abuse and Workplace Fraud: Evidence from Physicians
Journal of Business Ethics (2023)
-
Clinical, Cognitive, and Neurobiological Correlates of Impaired Timing Abilities Associate to Cannabis Use: a Systematic Review
International Journal of Mental Health and Addiction (2023)
-
Chronic ∆-9-tetrahydrocannabinol administration delays acquisition of schedule-induced drinking in rats and retains long-lasting effects
Psychopharmacology (2022)
-
A naturalistic study of orally administered vs. inhaled legal market cannabis: cannabinoids exposure, intoxication, and impairment
Psychopharmacology (2022)
